Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PANACEA BIOTECH ALEMBIC PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 19.2 9.4 204.4% View Chart
P/BV x 7.4 3.7 202.5% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 ALEMBIC PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
PANACEA BIOTECH
Mar-19
ALEMBIC PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs664354 187.8%   
Low Rs412138 298.4%   
Sales per share (Unadj.) Rs208.774.6 279.9%  
Earnings per share (Unadj.) Rs31.06.7 464.1%  
Cash flow per share (Unadj.) Rs37.115.5 239.5%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.257.2 252.1%  
Shares outstanding (eoy) m188.5261.25 307.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.3 78.2%   
Avg P/E ratio x17.436.8 47.2%  
P/CF ratio (eoy) x14.515.9 91.4%  
Price / Book Value ratio x3.74.3 86.8%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46115,061 673.7%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m7,4671,471 507.7%   
Avg. sales/employee Rs ThNM1,973.6-  
Avg. wages/employee Rs ThNM635.6-  
Avg. net profit/employee Rs ThNM176.8-  
INCOME DATA
Net Sales Rs m39,3474,567 861.5%  
Other income Rs m9445 209.4%   
Total revenues Rs m39,4414,612 855.2%   
Gross profit Rs m8,7362,030 430.4%  
Depreciation Rs m1,152540 213.4%   
Interest Rs m1841,048 17.6%   
Profit before tax Rs m7,493486 1,541.2%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,56877 2,033.1%   
Profit after tax Rs m5,844409 1,428.4%  
Gross profit margin %22.244.4 50.0%  
Effective tax rate %20.915.9 131.9%   
Net profit margin %14.99.0 165.8%  
BALANCE SHEET DATA
Current assets Rs m19,5772,415 810.8%   
Current liabilities Rs m14,8969,077 164.1%   
Net working cap to sales %11.9-145.9 -8.2%  
Current ratio x1.30.3 494.1%  
Inventory Days Days9065 137.9%  
Debtors Days Days4571 64.0%  
Net fixed assets Rs m27,0978,333 325.2%   
Share capital Rs m37761 615.0%   
"Free" reserves Rs m26,8113,443 778.8%   
Net worth Rs m27,1883,504 775.9%   
Long term debt Rs m4,993461 1,082.6%   
Total assets Rs m47,77813,755 347.3%  
Interest coverage x41.71.5 2,848.9%   
Debt to equity ratio x0.20.1 139.5%  
Sales to assets ratio x0.80.3 248.0%   
Return on assets %12.610.6 119.1%  
Return on equity %21.511.7 184.1%  
Return on capital %23.638.7 61.0%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m19,4531,203 1,617.0%   
Fx outflow Rs m6,065467 1,299.6%   
Net fx Rs m13,388736 1,818.1%   
CASH FLOW
From Operations Rs m8,1201,049 774.2%  
From Investments Rs m-7,556-54 14,123.4%  
From Financial Activity Rs m590-1,011 -58.4%  
Net Cashflow Rs m1,153-20 -5,854.3%  

Share Holding

Indian Promoters % 74.1 74.5 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.6 483.3%  
FIIs % 9.1 1.3 700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 23.6 58.9%  
Shareholders   49,328 10,259 480.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  NEULAND LABS  BIOCON   J.B.CHEMICALS  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 470 Points Lower; Tata Motors & Tata Steel Fall 6%(Closing)

Indian share markets witnessed huge selling pressure today, in line with global equities and fell on to bearish territory.

Related Views on News

The BSE HEALTHCARE Index Down 2% ; DISHMAN CARBOGEN AMCIS Among Top Losers (Market Updates)

Jan 18, 2021 | Updated on Jan 18, 2021

The BSE HEALTHCARE Index Down at 22,079 (down 2.0%). Among the top losers in the BSE HEALTHCARE Index today are DISHMAN CARBOGEN AMCIS, JUBILANT LIFE SCIENCES and SHALBY . Meanwhile, the BSE Sensex has plunged 0.6% to 49,122.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 18, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS